These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22137446)

  • 1. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.
    Melamud L; Golan D; Luboshitzky R; Lavi I; Miller A
    J Neurol Sci; 2012 Mar; 314(1-2):37-40. PubMed ID: 22137446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
    Mendozzi L; Tronci F; Garegnani M; Pugnetti L
    Mult Scler; 2010 Feb; 16(2):238-47. PubMed ID: 20028705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of sleep disturbances and fatigue in multiple sclerosis.
    Attarian HP; Brown KM; Duntley SP; Carter JD; Cross AH
    Arch Neurol; 2004 Apr; 61(4):525-8. PubMed ID: 15096400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.
    Golan D; Staun-Ram E; Glass-Marmor L; Lavi I; Rozenberg O; Dishon S; Barak M; Ish-Shalom S; Miller A
    Brain Behav Immun; 2013 Aug; 32():180-5. PubMed ID: 23665342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
    Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older poor-sleeping women display a smaller evening increase in melatonin secretion and lower values of melatonin and core body temperature than good sleepers.
    Olbrich D; Dittmar M
    Chronobiol Int; 2011 Oct; 28(8):681-9. PubMed ID: 21929299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients.
    Jonas M; Garfinkel D; Zisapel N; Laudon M; Grossman E
    Blood Press; 2003; 12(1):19-24. PubMed ID: 12699131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep--wake and body core temperature rhythms in multiple sclerosis with fatigue.
    Vetrugno R; Stecchi S; Scandellari C; Pierangeli G; Sabattini L; D'Angelo R; Provini F; Plazzi G; Cortelli P; Montagna P
    Clin Neurophysiol; 2007 Jan; 118(1):228-34. PubMed ID: 17095290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
    Damasceno A; Moraes AS; Farias A; Damasceno BP; dos Santos LM; Cendes F
    J Neurol Sci; 2015; 353(1-2):166-8. PubMed ID: 25930714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction.
    Kaminska M; Kimoff RJ; Schwartzman K; Trojan DA
    J Neurol Sci; 2011 Mar; 302(1-2):7-13. PubMed ID: 21241993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Govoni V; Caniatti L; Paolino E; Tola MR; Granieri E; Baricordi OR
    J Neuroimmunol; 2004 Mar; 148(1-2):206-11. PubMed ID: 14975603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
    Masruha MR; Lin J; de Souza Vieira DS; Minett TS; Cipolla-Neto J; Zukerman E; Vilanova LC; Peres MF
    Headache; 2010 Mar; 50(3):413-9. PubMed ID: 19817880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom clusters in women with relapsing-remitting multiple sclerosis.
    Newland PK; Fearing A; Riley M; Neath A
    J Neurosci Nurs; 2012 Apr; 44(2):66-71. PubMed ID: 22367268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ; Sellebjerg F; Krakauer M; Hesse D; Bendtzen K; Nielsen CH
    Mult Scler; 2011 May; 17(5):567-77. PubMed ID: 21177756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β.
    Melanson M; Grossberndt A; Klowak M; Leong C; Frost EE; Prout M; Le Dorze JA; Gramlich C; Doupe M; Wong L; Esfahani F; Gomori A; Namaka M
    Int J Neurosci; 2010 Oct; 120(10):631-40. PubMed ID: 20942577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
    Meca-Lallana JE; de Mingo-Casado P; Amorin-Díaz M; Martínez-Navarro ML; Barreiro AF
    Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
    Veauthier C; Radbruch H; Gaede G; Pfueller CF; Dörr J; Bellmann-Strobl J; Wernecke KD; Zipp F; Paul F; Sieb JP
    Mult Scler; 2011 May; 17(5):613-22. PubMed ID: 21278050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
    Bernal F; Elias B; Hartung HP; Kieseier BC
    Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report.
    Wulff K; Joyce E; Middleton B; Dijk DJ; Foster RG
    Chronobiol Int; 2006; 23(1-2):485-95. PubMed ID: 16687321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.